Login / Signup

Letter by Gronda et al Regarding Article, "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial".

Edoardo G GrondaFurio ColivicchiGiuseppe Zuccalà
Published in: Circulation (2022)
Keyphrases
  • ejection fraction
  • heart failure
  • aortic stenosis
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • left ventricular
  • atrial fibrillation
  • randomized controlled trial
  • open label